Global Biosynthesis of Cannabinoids Market Insights, Forecast to 2029
This report presents an overview of global market for Biosynthesis of Cannabinoids market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Biosynthesis of Cannabinoids, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Biosynthesis of Cannabinoids, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Biosynthesis of Cannabinoids revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Biosynthesis of Cannabinoids market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Biosynthesis of Cannabinoids revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Anandia Laboratories, Gingko Bioworks, Hyasynth Bio, InMed Pharmaceuticals, Librede, Renew Biopharma, Cronos Group, Organigram and Teewinot Life Sciences, etc.
By Company
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Biosynthesis of Cannabinoids in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biosynthesis of Cannabinoids companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biosynthesis of Cannabinoids revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
This report researches the key producers of Biosynthesis of Cannabinoids, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Biosynthesis of Cannabinoids, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Biosynthesis of Cannabinoids revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Biosynthesis of Cannabinoids market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Biosynthesis of Cannabinoids revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Anandia Laboratories, Gingko Bioworks, Hyasynth Bio, InMed Pharmaceuticals, Librede, Renew Biopharma, Cronos Group, Organigram and Teewinot Life Sciences, etc.
By Company
- Anandia Laboratories
- Gingko Bioworks
- Hyasynth Bio
- InMed Pharmaceuticals
- Librede
- Renew Biopharma
- Cronos Group
- Organigram
- Teewinot Life Sciences
- ICC International Cannabis Corp.
- Biotii Technologies Corp.
- Bristol-Myers Squibb
- Biogen Inc.
- GW Pharmaceuticals
- THC
- CBD
- Others
- Food Industry
- Medical Industry
- Others
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East, Africa, and Latin America
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Biosynthesis of Cannabinoids in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biosynthesis of Cannabinoids companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biosynthesis of Cannabinoids revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biosynthesis of Cannabinoids Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 THC
1.2.3 CBD
1.2.4 Others
1.3 Market by Application
1.3.1 Global Biosynthesis of Cannabinoids Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Food Industry
1.3.3 Medical Industry
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Biosynthesis of Cannabinoids Market Perspective (2018-2029)
2.2 Global Biosynthesis of Cannabinoids Growth Trends by Region
2.2.1 Biosynthesis of Cannabinoids Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Biosynthesis of Cannabinoids Historic Market Size by Region (2018-2023)
2.2.3 Biosynthesis of Cannabinoids Forecasted Market Size by Region (2024-2029)
2.3 Biosynthesis of Cannabinoids Market Dynamics
2.3.1 Biosynthesis of Cannabinoids Industry Trends
2.3.2 Biosynthesis of Cannabinoids Market Drivers
2.3.3 Biosynthesis of Cannabinoids Market Challenges
2.3.4 Biosynthesis of Cannabinoids Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Revenue Biosynthesis of Cannabinoids by Players
3.1.1 Global Biosynthesis of Cannabinoids Revenue by Players (2018-2023)
3.1.2 Global Biosynthesis of Cannabinoids Revenue Market Share by Players (2018-2023)
3.2 Global Biosynthesis of Cannabinoids Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Biosynthesis of Cannabinoids, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Biosynthesis of Cannabinoids Market Concentration Ratio
3.4.1 Global Biosynthesis of Cannabinoids Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biosynthesis of Cannabinoids Revenue in 2022
3.5 Global Key Players of Biosynthesis of Cannabinoids Head office and Area Served
3.6 Global Key Players of Biosynthesis of Cannabinoids, Product and Application
3.7 Global Key Players of Biosynthesis of Cannabinoids, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 BIOSYNTHESIS OF CANNABINOIDS BREAKDOWN DATA BY TYPE
4.1 Global Biosynthesis of Cannabinoids Historic Market Size by Type (2018-2023)
4.2 Global Biosynthesis of Cannabinoids Forecasted Market Size by Type (2024-2029)
5 BIOSYNTHESIS OF CANNABINOIDS BREAKDOWN DATA BY APPLICATION
5.1 Global Biosynthesis of Cannabinoids Historic Market Size by Application (2018-2023)
5.2 Global Biosynthesis of Cannabinoids Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Biosynthesis of Cannabinoids Market Size (2018-2029)
6.2 North America Biosynthesis of Cannabinoids Market Size by Type
6.2.1 North America Biosynthesis of Cannabinoids Market Size by Type (2018-2023)
6.2.2 North America Biosynthesis of Cannabinoids Market Size by Type (2024-2029)
6.2.3 North America Biosynthesis of Cannabinoids Market Share by Type (2018-2029)
6.3 North America Biosynthesis of Cannabinoids Market Size by Application
6.3.1 North America Biosynthesis of Cannabinoids Market Size by Application (2018-2023)
6.3.2 North America Biosynthesis of Cannabinoids Market Size by Application (2024-2029)
6.3.3 North America Biosynthesis of Cannabinoids Market Share by Application (2018-2029)
6.4 North America Biosynthesis of Cannabinoids Market Size by Country
6.4.1 North America Biosynthesis of Cannabinoids Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Biosynthesis of Cannabinoids Market Size by Country (2018-2023)
6.4.3 North America Biosynthesis of Cannabinoids Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 EUROPE
7.1 Europe Biosynthesis of Cannabinoids Market Size (2018-2029)
7.2 Europe Biosynthesis of Cannabinoids Market Size by Type
7.2.1 Europe Biosynthesis of Cannabinoids Market Size by Type (2018-2023)
7.2.2 Europe Biosynthesis of Cannabinoids Market Size by Type (2024-2029)
7.2.3 Europe Biosynthesis of Cannabinoids Market Share by Type (2018-2029)
7.3 Europe Biosynthesis of Cannabinoids Market Size by Application
7.3.1 Europe Biosynthesis of Cannabinoids Market Size by Application (2018-2023)
7.3.2 Europe Biosynthesis of Cannabinoids Market Size by Application (2024-2029)
7.3.3 Europe Biosynthesis of Cannabinoids Market Share by Application (2018-2029)
7.4 Europe Biosynthesis of Cannabinoids Market Size by Country
7.4.1 Europe Biosynthesis of Cannabinoids Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Biosynthesis of Cannabinoids Market Size by Country (2018-2023)
7.4.3 Europe Biosynthesis of Cannabinoids Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 CHINA
8.1 China Biosynthesis of Cannabinoids Market Size (2018-2029)
8.2 China Biosynthesis of Cannabinoids Market Size by Type
8.2.1 China Biosynthesis of Cannabinoids Market Size by Type (2018-2023)
8.2.2 China Biosynthesis of Cannabinoids Market Size by Type (2024-2029)
8.2.3 China Biosynthesis of Cannabinoids Market Share by Type (2018-2029)
8.3 China Biosynthesis of Cannabinoids Market Size by Application
8.3.1 China Biosynthesis of Cannabinoids Market Size by Application (2018-2023)
8.3.2 China Biosynthesis of Cannabinoids Market Size by Application (2024-2029)
8.3.3 China Biosynthesis of Cannabinoids Market Share by Application (2018-2029)
9 ASIA (EXCLUDING CHINA)
9.1 Asia Biosynthesis of Cannabinoids Market Size (2018-2029)
9.2 Asia Biosynthesis of Cannabinoids Market Size by Type
9.2.1 Asia Biosynthesis of Cannabinoids Market Size by Type (2018-2023)
9.2.2 Asia Biosynthesis of Cannabinoids Market Size by Type (2024-2029)
9.2.3 Asia Biosynthesis of Cannabinoids Market Share by Type (2018-2029)
9.3 Asia Biosynthesis of Cannabinoids Market Size by Application
9.3.1 Asia Biosynthesis of Cannabinoids Market Size by Application (2018-2023)
9.3.2 Asia Biosynthesis of Cannabinoids Market Size by Application (2024-2029)
9.3.3 Asia Biosynthesis of Cannabinoids Market Share by Application (2018-2029)
9.4 Asia Biosynthesis of Cannabinoids Market Size by Region
9.4.1 Asia Biosynthesis of Cannabinoids Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Biosynthesis of Cannabinoids Market Size by Region (2018-2023)
9.4.3 Asia Biosynthesis of Cannabinoids Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 MIDDLE EAST, AFRICA, AND LATIN AMERICA
10.1 Middle East, Africa, and Latin America Biosynthesis of Cannabinoids Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Biosynthesis of Cannabinoids Market Size by Type
10.2.1 Middle East, Africa, and Latin America Biosynthesis of Cannabinoids Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Biosynthesis of Cannabinoids Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Biosynthesis of Cannabinoids Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Biosynthesis of Cannabinoids Market Size by Application
10.3.1 Middle East, Africa, and Latin America Biosynthesis of Cannabinoids Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Biosynthesis of Cannabinoids Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Biosynthesis of Cannabinoids Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Biosynthesis of Cannabinoids Market Size by Country
10.4.1 Middle East, Africa, and Latin America Biosynthesis of Cannabinoids Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Biosynthesis of Cannabinoids Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Biosynthesis of Cannabinoids Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 KEY PLAYERS PROFILES
11.1 Anandia Laboratories
11.1.1 Anandia Laboratories Company Details
11.1.2 Anandia Laboratories Business Overview
11.1.3 Anandia Laboratories Biosynthesis of Cannabinoids Introduction
11.1.4 Anandia Laboratories Revenue in Biosynthesis of Cannabinoids Business (2018-2023)
11.1.5 Anandia Laboratories Recent Developments
11.2 Gingko Bioworks
11.2.1 Gingko Bioworks Company Details
11.2.2 Gingko Bioworks Business Overview
11.2.3 Gingko Bioworks Biosynthesis of Cannabinoids Introduction
11.2.4 Gingko Bioworks Revenue in Biosynthesis of Cannabinoids Business (2018-2023)
11.2.5 Gingko Bioworks Recent Developments
11.3 Hyasynth Bio
11.3.1 Hyasynth Bio Company Details
11.3.2 Hyasynth Bio Business Overview
11.3.3 Hyasynth Bio Biosynthesis of Cannabinoids Introduction
11.3.4 Hyasynth Bio Revenue in Biosynthesis of Cannabinoids Business (2018-2023)
11.3.5 Hyasynth Bio Recent Developments
11.4 InMed Pharmaceuticals
11.4.1 InMed Pharmaceuticals Company Details
11.4.2 InMed Pharmaceuticals Business Overview
11.4.3 InMed Pharmaceuticals Biosynthesis of Cannabinoids Introduction
11.4.4 InMed Pharmaceuticals Revenue in Biosynthesis of Cannabinoids Business (2018-2023)
11.4.5 InMed Pharmaceuticals Recent Developments
11.5 Librede
11.5.1 Librede Company Details
11.5.2 Librede Business Overview
11.5.3 Librede Biosynthesis of Cannabinoids Introduction
11.5.4 Librede Revenue in Biosynthesis of Cannabinoids Business (2018-2023)
11.5.5 Librede Recent Developments
11.6 Renew Biopharma
11.6.1 Renew Biopharma Company Details
11.6.2 Renew Biopharma Business Overview
11.6.3 Renew Biopharma Biosynthesis of Cannabinoids Introduction
11.6.4 Renew Biopharma Revenue in Biosynthesis of Cannabinoids Business (2018-2023)
11.6.5 Renew Biopharma Recent Developments
11.7 Cronos Group
11.7.1 Cronos Group Company Details
11.7.2 Cronos Group Business Overview
11.7.3 Cronos Group Biosynthesis of Cannabinoids Introduction
11.7.4 Cronos Group Revenue in Biosynthesis of Cannabinoids Business (2018-2023)
11.7.5 Cronos Group Recent Developments
11.8 Organigram
11.8.1 Organigram Company Details
11.8.2 Organigram Business Overview
11.8.3 Organigram Biosynthesis of Cannabinoids Introduction
11.8.4 Organigram Revenue in Biosynthesis of Cannabinoids Business (2018-2023)
11.8.5 Organigram Recent Developments
11.9 Teewinot Life Sciences
11.9.1 Teewinot Life Sciences Company Details
11.9.2 Teewinot Life Sciences Business Overview
11.9.3 Teewinot Life Sciences Biosynthesis of Cannabinoids Introduction
11.9.4 Teewinot Life Sciences Revenue in Biosynthesis of Cannabinoids Business (2018-2023)
11.9.5 Teewinot Life Sciences Recent Developments
11.10 ICC International Cannabis Corp.
11.10.1 ICC International Cannabis Corp. Company Details
11.10.2 ICC International Cannabis Corp. Business Overview
11.10.3 ICC International Cannabis Corp. Biosynthesis of Cannabinoids Introduction
11.10.4 ICC International Cannabis Corp. Revenue in Biosynthesis of Cannabinoids Business (2018-2023)
11.10.5 ICC International Cannabis Corp. Recent Developments
11.11 Biotii Technologies Corp.
11.11.1 Biotii Technologies Corp. Company Details
11.11.2 Biotii Technologies Corp. Business Overview
11.11.3 Biotii Technologies Corp. Biosynthesis of Cannabinoids Introduction
11.11.4 Biotii Technologies Corp. Revenue in Biosynthesis of Cannabinoids Business (2018-2023)
11.11.5 Biotii Technologies Corp. Recent Developments
11.12 Bristol-Myers Squibb
11.12.1 Bristol-Myers Squibb Company Details
11.12.2 Bristol-Myers Squibb Business Overview
11.12.3 Bristol-Myers Squibb Biosynthesis of Cannabinoids Introduction
11.12.4 Bristol-Myers Squibb Revenue in Biosynthesis of Cannabinoids Business (2018-2023)
11.12.5 Bristol-Myers Squibb Recent Developments
11.13 Biogen Inc.
11.13.1 Biogen Inc. Company Details
11.13.2 Biogen Inc. Business Overview
11.13.3 Biogen Inc. Biosynthesis of Cannabinoids Introduction
11.13.4 Biogen Inc. Revenue in Biosynthesis of Cannabinoids Business (2018-2023)
11.13.5 Biogen Inc. Recent Developments
11.14 GW Pharmaceuticals
11.14.1 GW Pharmaceuticals Company Details
11.14.2 GW Pharmaceuticals Business Overview
11.14.3 GW Pharmaceuticals Biosynthesis of Cannabinoids Introduction
11.14.4 GW Pharmaceuticals Revenue in Biosynthesis of Cannabinoids Business (2018-2023)
11.14.5 GW Pharmaceuticals Recent Developments
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biosynthesis of Cannabinoids Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 THC
1.2.3 CBD
1.2.4 Others
1.3 Market by Application
1.3.1 Global Biosynthesis of Cannabinoids Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Food Industry
1.3.3 Medical Industry
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Biosynthesis of Cannabinoids Market Perspective (2018-2029)
2.2 Global Biosynthesis of Cannabinoids Growth Trends by Region
2.2.1 Biosynthesis of Cannabinoids Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Biosynthesis of Cannabinoids Historic Market Size by Region (2018-2023)
2.2.3 Biosynthesis of Cannabinoids Forecasted Market Size by Region (2024-2029)
2.3 Biosynthesis of Cannabinoids Market Dynamics
2.3.1 Biosynthesis of Cannabinoids Industry Trends
2.3.2 Biosynthesis of Cannabinoids Market Drivers
2.3.3 Biosynthesis of Cannabinoids Market Challenges
2.3.4 Biosynthesis of Cannabinoids Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Revenue Biosynthesis of Cannabinoids by Players
3.1.1 Global Biosynthesis of Cannabinoids Revenue by Players (2018-2023)
3.1.2 Global Biosynthesis of Cannabinoids Revenue Market Share by Players (2018-2023)
3.2 Global Biosynthesis of Cannabinoids Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Biosynthesis of Cannabinoids, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Biosynthesis of Cannabinoids Market Concentration Ratio
3.4.1 Global Biosynthesis of Cannabinoids Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biosynthesis of Cannabinoids Revenue in 2022
3.5 Global Key Players of Biosynthesis of Cannabinoids Head office and Area Served
3.6 Global Key Players of Biosynthesis of Cannabinoids, Product and Application
3.7 Global Key Players of Biosynthesis of Cannabinoids, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 BIOSYNTHESIS OF CANNABINOIDS BREAKDOWN DATA BY TYPE
4.1 Global Biosynthesis of Cannabinoids Historic Market Size by Type (2018-2023)
4.2 Global Biosynthesis of Cannabinoids Forecasted Market Size by Type (2024-2029)
5 BIOSYNTHESIS OF CANNABINOIDS BREAKDOWN DATA BY APPLICATION
5.1 Global Biosynthesis of Cannabinoids Historic Market Size by Application (2018-2023)
5.2 Global Biosynthesis of Cannabinoids Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Biosynthesis of Cannabinoids Market Size (2018-2029)
6.2 North America Biosynthesis of Cannabinoids Market Size by Type
6.2.1 North America Biosynthesis of Cannabinoids Market Size by Type (2018-2023)
6.2.2 North America Biosynthesis of Cannabinoids Market Size by Type (2024-2029)
6.2.3 North America Biosynthesis of Cannabinoids Market Share by Type (2018-2029)
6.3 North America Biosynthesis of Cannabinoids Market Size by Application
6.3.1 North America Biosynthesis of Cannabinoids Market Size by Application (2018-2023)
6.3.2 North America Biosynthesis of Cannabinoids Market Size by Application (2024-2029)
6.3.3 North America Biosynthesis of Cannabinoids Market Share by Application (2018-2029)
6.4 North America Biosynthesis of Cannabinoids Market Size by Country
6.4.1 North America Biosynthesis of Cannabinoids Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Biosynthesis of Cannabinoids Market Size by Country (2018-2023)
6.4.3 North America Biosynthesis of Cannabinoids Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 EUROPE
7.1 Europe Biosynthesis of Cannabinoids Market Size (2018-2029)
7.2 Europe Biosynthesis of Cannabinoids Market Size by Type
7.2.1 Europe Biosynthesis of Cannabinoids Market Size by Type (2018-2023)
7.2.2 Europe Biosynthesis of Cannabinoids Market Size by Type (2024-2029)
7.2.3 Europe Biosynthesis of Cannabinoids Market Share by Type (2018-2029)
7.3 Europe Biosynthesis of Cannabinoids Market Size by Application
7.3.1 Europe Biosynthesis of Cannabinoids Market Size by Application (2018-2023)
7.3.2 Europe Biosynthesis of Cannabinoids Market Size by Application (2024-2029)
7.3.3 Europe Biosynthesis of Cannabinoids Market Share by Application (2018-2029)
7.4 Europe Biosynthesis of Cannabinoids Market Size by Country
7.4.1 Europe Biosynthesis of Cannabinoids Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Biosynthesis of Cannabinoids Market Size by Country (2018-2023)
7.4.3 Europe Biosynthesis of Cannabinoids Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 CHINA
8.1 China Biosynthesis of Cannabinoids Market Size (2018-2029)
8.2 China Biosynthesis of Cannabinoids Market Size by Type
8.2.1 China Biosynthesis of Cannabinoids Market Size by Type (2018-2023)
8.2.2 China Biosynthesis of Cannabinoids Market Size by Type (2024-2029)
8.2.3 China Biosynthesis of Cannabinoids Market Share by Type (2018-2029)
8.3 China Biosynthesis of Cannabinoids Market Size by Application
8.3.1 China Biosynthesis of Cannabinoids Market Size by Application (2018-2023)
8.3.2 China Biosynthesis of Cannabinoids Market Size by Application (2024-2029)
8.3.3 China Biosynthesis of Cannabinoids Market Share by Application (2018-2029)
9 ASIA (EXCLUDING CHINA)
9.1 Asia Biosynthesis of Cannabinoids Market Size (2018-2029)
9.2 Asia Biosynthesis of Cannabinoids Market Size by Type
9.2.1 Asia Biosynthesis of Cannabinoids Market Size by Type (2018-2023)
9.2.2 Asia Biosynthesis of Cannabinoids Market Size by Type (2024-2029)
9.2.3 Asia Biosynthesis of Cannabinoids Market Share by Type (2018-2029)
9.3 Asia Biosynthesis of Cannabinoids Market Size by Application
9.3.1 Asia Biosynthesis of Cannabinoids Market Size by Application (2018-2023)
9.3.2 Asia Biosynthesis of Cannabinoids Market Size by Application (2024-2029)
9.3.3 Asia Biosynthesis of Cannabinoids Market Share by Application (2018-2029)
9.4 Asia Biosynthesis of Cannabinoids Market Size by Region
9.4.1 Asia Biosynthesis of Cannabinoids Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Biosynthesis of Cannabinoids Market Size by Region (2018-2023)
9.4.3 Asia Biosynthesis of Cannabinoids Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 MIDDLE EAST, AFRICA, AND LATIN AMERICA
10.1 Middle East, Africa, and Latin America Biosynthesis of Cannabinoids Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Biosynthesis of Cannabinoids Market Size by Type
10.2.1 Middle East, Africa, and Latin America Biosynthesis of Cannabinoids Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Biosynthesis of Cannabinoids Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Biosynthesis of Cannabinoids Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Biosynthesis of Cannabinoids Market Size by Application
10.3.1 Middle East, Africa, and Latin America Biosynthesis of Cannabinoids Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Biosynthesis of Cannabinoids Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Biosynthesis of Cannabinoids Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Biosynthesis of Cannabinoids Market Size by Country
10.4.1 Middle East, Africa, and Latin America Biosynthesis of Cannabinoids Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Biosynthesis of Cannabinoids Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Biosynthesis of Cannabinoids Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 KEY PLAYERS PROFILES
11.1 Anandia Laboratories
11.1.1 Anandia Laboratories Company Details
11.1.2 Anandia Laboratories Business Overview
11.1.3 Anandia Laboratories Biosynthesis of Cannabinoids Introduction
11.1.4 Anandia Laboratories Revenue in Biosynthesis of Cannabinoids Business (2018-2023)
11.1.5 Anandia Laboratories Recent Developments
11.2 Gingko Bioworks
11.2.1 Gingko Bioworks Company Details
11.2.2 Gingko Bioworks Business Overview
11.2.3 Gingko Bioworks Biosynthesis of Cannabinoids Introduction
11.2.4 Gingko Bioworks Revenue in Biosynthesis of Cannabinoids Business (2018-2023)
11.2.5 Gingko Bioworks Recent Developments
11.3 Hyasynth Bio
11.3.1 Hyasynth Bio Company Details
11.3.2 Hyasynth Bio Business Overview
11.3.3 Hyasynth Bio Biosynthesis of Cannabinoids Introduction
11.3.4 Hyasynth Bio Revenue in Biosynthesis of Cannabinoids Business (2018-2023)
11.3.5 Hyasynth Bio Recent Developments
11.4 InMed Pharmaceuticals
11.4.1 InMed Pharmaceuticals Company Details
11.4.2 InMed Pharmaceuticals Business Overview
11.4.3 InMed Pharmaceuticals Biosynthesis of Cannabinoids Introduction
11.4.4 InMed Pharmaceuticals Revenue in Biosynthesis of Cannabinoids Business (2018-2023)
11.4.5 InMed Pharmaceuticals Recent Developments
11.5 Librede
11.5.1 Librede Company Details
11.5.2 Librede Business Overview
11.5.3 Librede Biosynthesis of Cannabinoids Introduction
11.5.4 Librede Revenue in Biosynthesis of Cannabinoids Business (2018-2023)
11.5.5 Librede Recent Developments
11.6 Renew Biopharma
11.6.1 Renew Biopharma Company Details
11.6.2 Renew Biopharma Business Overview
11.6.3 Renew Biopharma Biosynthesis of Cannabinoids Introduction
11.6.4 Renew Biopharma Revenue in Biosynthesis of Cannabinoids Business (2018-2023)
11.6.5 Renew Biopharma Recent Developments
11.7 Cronos Group
11.7.1 Cronos Group Company Details
11.7.2 Cronos Group Business Overview
11.7.3 Cronos Group Biosynthesis of Cannabinoids Introduction
11.7.4 Cronos Group Revenue in Biosynthesis of Cannabinoids Business (2018-2023)
11.7.5 Cronos Group Recent Developments
11.8 Organigram
11.8.1 Organigram Company Details
11.8.2 Organigram Business Overview
11.8.3 Organigram Biosynthesis of Cannabinoids Introduction
11.8.4 Organigram Revenue in Biosynthesis of Cannabinoids Business (2018-2023)
11.8.5 Organigram Recent Developments
11.9 Teewinot Life Sciences
11.9.1 Teewinot Life Sciences Company Details
11.9.2 Teewinot Life Sciences Business Overview
11.9.3 Teewinot Life Sciences Biosynthesis of Cannabinoids Introduction
11.9.4 Teewinot Life Sciences Revenue in Biosynthesis of Cannabinoids Business (2018-2023)
11.9.5 Teewinot Life Sciences Recent Developments
11.10 ICC International Cannabis Corp.
11.10.1 ICC International Cannabis Corp. Company Details
11.10.2 ICC International Cannabis Corp. Business Overview
11.10.3 ICC International Cannabis Corp. Biosynthesis of Cannabinoids Introduction
11.10.4 ICC International Cannabis Corp. Revenue in Biosynthesis of Cannabinoids Business (2018-2023)
11.10.5 ICC International Cannabis Corp. Recent Developments
11.11 Biotii Technologies Corp.
11.11.1 Biotii Technologies Corp. Company Details
11.11.2 Biotii Technologies Corp. Business Overview
11.11.3 Biotii Technologies Corp. Biosynthesis of Cannabinoids Introduction
11.11.4 Biotii Technologies Corp. Revenue in Biosynthesis of Cannabinoids Business (2018-2023)
11.11.5 Biotii Technologies Corp. Recent Developments
11.12 Bristol-Myers Squibb
11.12.1 Bristol-Myers Squibb Company Details
11.12.2 Bristol-Myers Squibb Business Overview
11.12.3 Bristol-Myers Squibb Biosynthesis of Cannabinoids Introduction
11.12.4 Bristol-Myers Squibb Revenue in Biosynthesis of Cannabinoids Business (2018-2023)
11.12.5 Bristol-Myers Squibb Recent Developments
11.13 Biogen Inc.
11.13.1 Biogen Inc. Company Details
11.13.2 Biogen Inc. Business Overview
11.13.3 Biogen Inc. Biosynthesis of Cannabinoids Introduction
11.13.4 Biogen Inc. Revenue in Biosynthesis of Cannabinoids Business (2018-2023)
11.13.5 Biogen Inc. Recent Developments
11.14 GW Pharmaceuticals
11.14.1 GW Pharmaceuticals Company Details
11.14.2 GW Pharmaceuticals Business Overview
11.14.3 GW Pharmaceuticals Biosynthesis of Cannabinoids Introduction
11.14.4 GW Pharmaceuticals Revenue in Biosynthesis of Cannabinoids Business (2018-2023)
11.14.5 GW Pharmaceuticals Recent Developments
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
LIST OF TABLES
Table 1. Global Biosynthesis of Cannabinoids Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of THC
Table 3. Key Players of CBD
Table 4. Key Players of Others
Table 5. Global Biosynthesis of Cannabinoids Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 6. Global Biosynthesis of Cannabinoids Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Biosynthesis of Cannabinoids Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Biosynthesis of Cannabinoids Market Share by Region (2018-2023)
Table 9. Global Biosynthesis of Cannabinoids Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Biosynthesis of Cannabinoids Market Share by Region (2024-2029)
Table 11. Biosynthesis of Cannabinoids Market Trends
Table 12. Biosynthesis of Cannabinoids Market Drivers
Table 13. Biosynthesis of Cannabinoids Market Challenges
Table 14. Biosynthesis of Cannabinoids Market Restraints
Table 15. Global Biosynthesis of Cannabinoids Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Biosynthesis of Cannabinoids Revenue Share by Players (2018-2023)
Table 17. Global Top Biosynthesis of Cannabinoids by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biosynthesis of Cannabinoids as of 2022)
Table 18. Global Biosynthesis of Cannabinoids Industry Ranking 2021 VS 2022 VS 2023
Table 19. Global 5 Largest Players Market Share by Biosynthesis of Cannabinoids Revenue (CR5 and HHI) & (2018-2023)
Table 20. Global Key Players of Biosynthesis of Cannabinoids, Headquarters and Area Served
Table 21. Global Key Players of Biosynthesis of Cannabinoids, Product and Application
Table 22. Global Key Players of Biosynthesis of Cannabinoids, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Biosynthesis of Cannabinoids Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Biosynthesis of Cannabinoids Revenue Market Share by Type (2018-2023)
Table 26. Global Biosynthesis of Cannabinoids Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Biosynthesis of Cannabinoids Revenue Market Share by Type (2024-2029)
Table 28. Global Biosynthesis of Cannabinoids Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Biosynthesis of Cannabinoids Revenue Share by Application (2018-2023)
Table 30. Global Biosynthesis of Cannabinoids Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Biosynthesis of Cannabinoids Revenue Share by Application (2024-2029)
Table 32. North America Biosynthesis of Cannabinoids Market Size by Type (2018-2023) & (US$ Million)
Table 33. North America Biosynthesis of Cannabinoids Market Size by Type (2024-2029) & (US$ Million)
Table 34. North America Biosynthesis of Cannabinoids Market Size by Application (2018-2023) & (US$ Million)
Table 35. North America Biosynthesis of Cannabinoids Market Size by Application (2024-2029) & (US$ Million)
Table 36. North America Biosynthesis of Cannabinoids Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. North America Biosynthesis of Cannabinoids Market Size by Country (2018-2023) & (US$ Million)
Table 38. North America Biosynthesis of Cannabinoids Market Size by Country (2024-2029) & (US$ Million)
Table 39. Europe Biosynthesis of Cannabinoids Market Size by Type (2018-2023) & (US$ Million)
Table 40. Europe Biosynthesis of Cannabinoids Market Size by Type (2024-2029) & (US$ Million)
Table 41. Europe Biosynthesis of Cannabinoids Market Size by Application (2018-2023) & (US$ Million)
Table 42. Europe Biosynthesis of Cannabinoids Market Size by Application (2024-2029) & (US$ Million)
Table 43. Europe Biosynthesis of Cannabinoids Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Europe Biosynthesis of Cannabinoids Market Size by Country (2018-2023) & (US$ Million)
Table 45. Europe Biosynthesis of Cannabinoids Market Size by Country (2024-2029) & (US$ Million)
Table 46. China Biosynthesis of Cannabinoids Market Size by Type (2018-2023) & (US$ Million)
Table 47. China Biosynthesis of Cannabinoids Market Size by Type (2024-2029) & (US$ Million)
Table 48. China Biosynthesis of Cannabinoids Market Size by Application (2018-2023) & (US$ Million)
Table 49. China Biosynthesis of Cannabinoids Market Size by Application (2024-2029) & (US$ Million)
Table 50. Asia Biosynthesis of Cannabinoids Market Size by Type (2018-2023) & (US$ Million)
Table 51. Asia Biosynthesis of Cannabinoids Market Size by Type (2024-2029) & (US$ Million)
Table 52. Asia Biosynthesis of Cannabinoids Market Size by Application (2018-2023) & (US$ Million)
Table 53. Asia Biosynthesis of Cannabinoids Market Size by Application (2024-2029) & (US$ Million)
Table 54. Asia Biosynthesis of Cannabinoids Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 55. Asia Biosynthesis of Cannabinoids Market Size by Region (2018-2023) & (US$ Million)
Table 56. Asia Biosynthesis of Cannabinoids Market Size by Region (2024-2029) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Biosynthesis of Cannabinoids Market Size by Type (2018-2023) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Biosynthesis of Cannabinoids Market Size by Type (2024-2029) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Biosynthesis of Cannabinoids Market Size by Application (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Biosynthesis of Cannabinoids Market Size by Application (2024-2029) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Biosynthesis of Cannabinoids Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 62. Middle East, Africa, and Latin America Biosynthesis of Cannabinoids Market Size by Country (2018-2023) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Biosynthesis of Cannabinoids Market Size by Country (2024-2029) & (US$ Million)
Table 64. Anandia Laboratories Company Details
Table 65. Anandia Laboratories Business Overview
Table 66. Anandia Laboratories Biosynthesis of Cannabinoids Product
Table 67. Anandia Laboratories Revenue in Biosynthesis of Cannabinoids Business (2018-2023) & (US$ Million)
Table 68. Anandia Laboratories Recent Developments
Table 69. Gingko Bioworks Company Details
Table 70. Gingko Bioworks Business Overview
Table 71. Gingko Bioworks Biosynthesis of Cannabinoids Product
Table 72. Gingko Bioworks Revenue in Biosynthesis of Cannabinoids Business (2018-2023) & (US$ Million)
Table 73. Gingko Bioworks Recent Developments
Table 74. Hyasynth Bio Company Details
Table 75. Hyasynth Bio Business Overview
Table 76. Hyasynth Bio Biosynthesis of Cannabinoids Product
Table 77. Hyasynth Bio Revenue in Biosynthesis of Cannabinoids Business (2018-2023) & (US$ Million)
Table 78. Hyasynth Bio Recent Developments
Table 79. InMed Pharmaceuticals Company Details
Table 80. InMed Pharmaceuticals Business Overview
Table 81. InMed Pharmaceuticals Biosynthesis of Cannabinoids Product
Table 82. InMed Pharmaceuticals Revenue in Biosynthesis of Cannabinoids Business (2018-2023) & (US$ Million)
Table 83. InMed Pharmaceuticals Recent Developments
Table 84. Librede Company Details
Table 85. Librede Business Overview
Table 86. Librede Biosynthesis of Cannabinoids Product
Table 87. Librede Revenue in Biosynthesis of Cannabinoids Business (2018-2023) & (US$ Million)
Table 88. Librede Recent Developments
Table 89. Renew Biopharma Company Details
Table 90. Renew Biopharma Business Overview
Table 91. Renew Biopharma Biosynthesis of Cannabinoids Product
Table 92. Renew Biopharma Revenue in Biosynthesis of Cannabinoids Business (2018-2023) & (US$ Million)
Table 93. Renew Biopharma Recent Developments
Table 94. Cronos Group Company Details
Table 95. Cronos Group Business Overview
Table 96. Cronos Group Biosynthesis of Cannabinoids Product
Table 97. Cronos Group Revenue in Biosynthesis of Cannabinoids Business (2018-2023) & (US$ Million)
Table 98. Cronos Group Recent Developments
Table 99. Organigram Company Details
Table 100. Organigram Business Overview
Table 101. Organigram Biosynthesis of Cannabinoids Product
Table 102. Organigram Revenue in Biosynthesis of Cannabinoids Business (2018-2023) & (US$ Million)
Table 103. Organigram Recent Developments
Table 104. Teewinot Life Sciences Company Details
Table 105. Teewinot Life Sciences Business Overview
Table 106. Teewinot Life Sciences Biosynthesis of Cannabinoids Product
Table 107. Teewinot Life Sciences Revenue in Biosynthesis of Cannabinoids Business (2018-2023) & (US$ Million)
Table 108. Teewinot Life Sciences Recent Developments
Table 109. ICC International Cannabis Corp. Company Details
Table 110. ICC International Cannabis Corp. Business Overview
Table 111. ICC International Cannabis Corp. Biosynthesis of Cannabinoids Product
Table 112. ICC International Cannabis Corp. Revenue in Biosynthesis of Cannabinoids Business (2018-2023) & (US$ Million)
Table 113. ICC International Cannabis Corp. Recent Developments
Table 114. Biotii Technologies Corp. Company Details
Table 115. Biotii Technologies Corp. Business Overview
Table 116. Biotii Technologies Corp. Biosynthesis of Cannabinoids Product
Table 117. Biotii Technologies Corp. Revenue in Biosynthesis of Cannabinoids Business (2018-2023) & (US$ Million)
Table 118. Biotii Technologies Corp. Recent Developments
Table 119. Bristol-Myers Squibb Company Details
Table 120. Bristol-Myers Squibb Business Overview
Table 121. Bristol-Myers Squibb Biosynthesis of Cannabinoids Product
Table 122. Bristol-Myers Squibb Revenue in Biosynthesis of Cannabinoids Business (2018-2023) & (US$ Million)
Table 123. Bristol-Myers Squibb Recent Developments
Table 124. Biogen Inc. Company Details
Table 125. Biogen Inc. Business Overview
Table 126. Biogen Inc. Biosynthesis of Cannabinoids Product
Table 127. Biogen Inc. Revenue in Biosynthesis of Cannabinoids Business (2018-2023) & (US$ Million)
Table 128. Biogen Inc. Recent Developments
Table 129. GW Pharmaceuticals Company Details
Table 130. GW Pharmaceuticals Business Overview
Table 131. GW Pharmaceuticals Biosynthesis of Cannabinoids Product
Table 132. GW Pharmaceuticals Revenue in Biosynthesis of Cannabinoids Business (2018-2023) & (US$ Million)
Table 133. GW Pharmaceuticals Recent Developments
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources
Table 1. Global Biosynthesis of Cannabinoids Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of THC
Table 3. Key Players of CBD
Table 4. Key Players of Others
Table 5. Global Biosynthesis of Cannabinoids Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 6. Global Biosynthesis of Cannabinoids Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Biosynthesis of Cannabinoids Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Biosynthesis of Cannabinoids Market Share by Region (2018-2023)
Table 9. Global Biosynthesis of Cannabinoids Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Biosynthesis of Cannabinoids Market Share by Region (2024-2029)
Table 11. Biosynthesis of Cannabinoids Market Trends
Table 12. Biosynthesis of Cannabinoids Market Drivers
Table 13. Biosynthesis of Cannabinoids Market Challenges
Table 14. Biosynthesis of Cannabinoids Market Restraints
Table 15. Global Biosynthesis of Cannabinoids Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Biosynthesis of Cannabinoids Revenue Share by Players (2018-2023)
Table 17. Global Top Biosynthesis of Cannabinoids by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biosynthesis of Cannabinoids as of 2022)
Table 18. Global Biosynthesis of Cannabinoids Industry Ranking 2021 VS 2022 VS 2023
Table 19. Global 5 Largest Players Market Share by Biosynthesis of Cannabinoids Revenue (CR5 and HHI) & (2018-2023)
Table 20. Global Key Players of Biosynthesis of Cannabinoids, Headquarters and Area Served
Table 21. Global Key Players of Biosynthesis of Cannabinoids, Product and Application
Table 22. Global Key Players of Biosynthesis of Cannabinoids, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Biosynthesis of Cannabinoids Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Biosynthesis of Cannabinoids Revenue Market Share by Type (2018-2023)
Table 26. Global Biosynthesis of Cannabinoids Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Biosynthesis of Cannabinoids Revenue Market Share by Type (2024-2029)
Table 28. Global Biosynthesis of Cannabinoids Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Biosynthesis of Cannabinoids Revenue Share by Application (2018-2023)
Table 30. Global Biosynthesis of Cannabinoids Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Biosynthesis of Cannabinoids Revenue Share by Application (2024-2029)
Table 32. North America Biosynthesis of Cannabinoids Market Size by Type (2018-2023) & (US$ Million)
Table 33. North America Biosynthesis of Cannabinoids Market Size by Type (2024-2029) & (US$ Million)
Table 34. North America Biosynthesis of Cannabinoids Market Size by Application (2018-2023) & (US$ Million)
Table 35. North America Biosynthesis of Cannabinoids Market Size by Application (2024-2029) & (US$ Million)
Table 36. North America Biosynthesis of Cannabinoids Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. North America Biosynthesis of Cannabinoids Market Size by Country (2018-2023) & (US$ Million)
Table 38. North America Biosynthesis of Cannabinoids Market Size by Country (2024-2029) & (US$ Million)
Table 39. Europe Biosynthesis of Cannabinoids Market Size by Type (2018-2023) & (US$ Million)
Table 40. Europe Biosynthesis of Cannabinoids Market Size by Type (2024-2029) & (US$ Million)
Table 41. Europe Biosynthesis of Cannabinoids Market Size by Application (2018-2023) & (US$ Million)
Table 42. Europe Biosynthesis of Cannabinoids Market Size by Application (2024-2029) & (US$ Million)
Table 43. Europe Biosynthesis of Cannabinoids Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Europe Biosynthesis of Cannabinoids Market Size by Country (2018-2023) & (US$ Million)
Table 45. Europe Biosynthesis of Cannabinoids Market Size by Country (2024-2029) & (US$ Million)
Table 46. China Biosynthesis of Cannabinoids Market Size by Type (2018-2023) & (US$ Million)
Table 47. China Biosynthesis of Cannabinoids Market Size by Type (2024-2029) & (US$ Million)
Table 48. China Biosynthesis of Cannabinoids Market Size by Application (2018-2023) & (US$ Million)
Table 49. China Biosynthesis of Cannabinoids Market Size by Application (2024-2029) & (US$ Million)
Table 50. Asia Biosynthesis of Cannabinoids Market Size by Type (2018-2023) & (US$ Million)
Table 51. Asia Biosynthesis of Cannabinoids Market Size by Type (2024-2029) & (US$ Million)
Table 52. Asia Biosynthesis of Cannabinoids Market Size by Application (2018-2023) & (US$ Million)
Table 53. Asia Biosynthesis of Cannabinoids Market Size by Application (2024-2029) & (US$ Million)
Table 54. Asia Biosynthesis of Cannabinoids Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 55. Asia Biosynthesis of Cannabinoids Market Size by Region (2018-2023) & (US$ Million)
Table 56. Asia Biosynthesis of Cannabinoids Market Size by Region (2024-2029) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Biosynthesis of Cannabinoids Market Size by Type (2018-2023) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Biosynthesis of Cannabinoids Market Size by Type (2024-2029) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Biosynthesis of Cannabinoids Market Size by Application (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Biosynthesis of Cannabinoids Market Size by Application (2024-2029) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Biosynthesis of Cannabinoids Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 62. Middle East, Africa, and Latin America Biosynthesis of Cannabinoids Market Size by Country (2018-2023) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Biosynthesis of Cannabinoids Market Size by Country (2024-2029) & (US$ Million)
Table 64. Anandia Laboratories Company Details
Table 65. Anandia Laboratories Business Overview
Table 66. Anandia Laboratories Biosynthesis of Cannabinoids Product
Table 67. Anandia Laboratories Revenue in Biosynthesis of Cannabinoids Business (2018-2023) & (US$ Million)
Table 68. Anandia Laboratories Recent Developments
Table 69. Gingko Bioworks Company Details
Table 70. Gingko Bioworks Business Overview
Table 71. Gingko Bioworks Biosynthesis of Cannabinoids Product
Table 72. Gingko Bioworks Revenue in Biosynthesis of Cannabinoids Business (2018-2023) & (US$ Million)
Table 73. Gingko Bioworks Recent Developments
Table 74. Hyasynth Bio Company Details
Table 75. Hyasynth Bio Business Overview
Table 76. Hyasynth Bio Biosynthesis of Cannabinoids Product
Table 77. Hyasynth Bio Revenue in Biosynthesis of Cannabinoids Business (2018-2023) & (US$ Million)
Table 78. Hyasynth Bio Recent Developments
Table 79. InMed Pharmaceuticals Company Details
Table 80. InMed Pharmaceuticals Business Overview
Table 81. InMed Pharmaceuticals Biosynthesis of Cannabinoids Product
Table 82. InMed Pharmaceuticals Revenue in Biosynthesis of Cannabinoids Business (2018-2023) & (US$ Million)
Table 83. InMed Pharmaceuticals Recent Developments
Table 84. Librede Company Details
Table 85. Librede Business Overview
Table 86. Librede Biosynthesis of Cannabinoids Product
Table 87. Librede Revenue in Biosynthesis of Cannabinoids Business (2018-2023) & (US$ Million)
Table 88. Librede Recent Developments
Table 89. Renew Biopharma Company Details
Table 90. Renew Biopharma Business Overview
Table 91. Renew Biopharma Biosynthesis of Cannabinoids Product
Table 92. Renew Biopharma Revenue in Biosynthesis of Cannabinoids Business (2018-2023) & (US$ Million)
Table 93. Renew Biopharma Recent Developments
Table 94. Cronos Group Company Details
Table 95. Cronos Group Business Overview
Table 96. Cronos Group Biosynthesis of Cannabinoids Product
Table 97. Cronos Group Revenue in Biosynthesis of Cannabinoids Business (2018-2023) & (US$ Million)
Table 98. Cronos Group Recent Developments
Table 99. Organigram Company Details
Table 100. Organigram Business Overview
Table 101. Organigram Biosynthesis of Cannabinoids Product
Table 102. Organigram Revenue in Biosynthesis of Cannabinoids Business (2018-2023) & (US$ Million)
Table 103. Organigram Recent Developments
Table 104. Teewinot Life Sciences Company Details
Table 105. Teewinot Life Sciences Business Overview
Table 106. Teewinot Life Sciences Biosynthesis of Cannabinoids Product
Table 107. Teewinot Life Sciences Revenue in Biosynthesis of Cannabinoids Business (2018-2023) & (US$ Million)
Table 108. Teewinot Life Sciences Recent Developments
Table 109. ICC International Cannabis Corp. Company Details
Table 110. ICC International Cannabis Corp. Business Overview
Table 111. ICC International Cannabis Corp. Biosynthesis of Cannabinoids Product
Table 112. ICC International Cannabis Corp. Revenue in Biosynthesis of Cannabinoids Business (2018-2023) & (US$ Million)
Table 113. ICC International Cannabis Corp. Recent Developments
Table 114. Biotii Technologies Corp. Company Details
Table 115. Biotii Technologies Corp. Business Overview
Table 116. Biotii Technologies Corp. Biosynthesis of Cannabinoids Product
Table 117. Biotii Technologies Corp. Revenue in Biosynthesis of Cannabinoids Business (2018-2023) & (US$ Million)
Table 118. Biotii Technologies Corp. Recent Developments
Table 119. Bristol-Myers Squibb Company Details
Table 120. Bristol-Myers Squibb Business Overview
Table 121. Bristol-Myers Squibb Biosynthesis of Cannabinoids Product
Table 122. Bristol-Myers Squibb Revenue in Biosynthesis of Cannabinoids Business (2018-2023) & (US$ Million)
Table 123. Bristol-Myers Squibb Recent Developments
Table 124. Biogen Inc. Company Details
Table 125. Biogen Inc. Business Overview
Table 126. Biogen Inc. Biosynthesis of Cannabinoids Product
Table 127. Biogen Inc. Revenue in Biosynthesis of Cannabinoids Business (2018-2023) & (US$ Million)
Table 128. Biogen Inc. Recent Developments
Table 129. GW Pharmaceuticals Company Details
Table 130. GW Pharmaceuticals Business Overview
Table 131. GW Pharmaceuticals Biosynthesis of Cannabinoids Product
Table 132. GW Pharmaceuticals Revenue in Biosynthesis of Cannabinoids Business (2018-2023) & (US$ Million)
Table 133. GW Pharmaceuticals Recent Developments
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Biosynthesis of Cannabinoids Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Biosynthesis of Cannabinoids Market Share by Type: 2022 VS 2029
Figure 3. THC Features
Figure 4. CBD Features
Figure 5. Others Features
Figure 6. Global Biosynthesis of Cannabinoids Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Biosynthesis of Cannabinoids Market Share by Application: 2022 VS 2029
Figure 8. Food Industry Case Studies
Figure 9. Medical Industry Case Studies
Figure 10. Others Case Studies
Figure 11. Biosynthesis of Cannabinoids Report Years Considered
Figure 12. Global Biosynthesis of Cannabinoids Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Biosynthesis of Cannabinoids Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Biosynthesis of Cannabinoids Market Share by Region: 2022 VS 2029
Figure 15. Global Biosynthesis of Cannabinoids Market Share by Players in 2022
Figure 16. Global Top Biosynthesis of Cannabinoids Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biosynthesis of Cannabinoids as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Biosynthesis of Cannabinoids Revenue in 2022
Figure 18. North America Biosynthesis of Cannabinoids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Biosynthesis of Cannabinoids Market Share by Type (2018-2029)
Figure 20. North America Biosynthesis of Cannabinoids Market Share by Application (2018-2029)
Figure 21. North America Biosynthesis of Cannabinoids Market Share by Country (2018-2029)
Figure 22. United States Biosynthesis of Cannabinoids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Canada Biosynthesis of Cannabinoids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Biosynthesis of Cannabinoids Market Size YoY (2018-2029) & (US$ Million)
Figure 25. Europe Biosynthesis of Cannabinoids Market Share by Type (2018-2029)
Figure 26. Europe Biosynthesis of Cannabinoids Market Share by Application (2018-2029)
Figure 27. Europe Biosynthesis of Cannabinoids Market Share by Country (2018-2029)
Figure 28. Germany Biosynthesis of Cannabinoids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. France Biosynthesis of Cannabinoids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. U.K. Biosynthesis of Cannabinoids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Italy Biosynthesis of Cannabinoids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Russia Biosynthesis of Cannabinoids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Nordic Countries Biosynthesis of Cannabinoids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. China Biosynthesis of Cannabinoids Market Size YoY (2018-2029) & (US$ Million)
Figure 35. China Biosynthesis of Cannabinoids Market Share by Type (2018-2029)
Figure 36. China Biosynthesis of Cannabinoids Market Share by Application (2018-2029)
Figure 37. Asia Biosynthesis of Cannabinoids Market Size YoY (2018-2029) & (US$ Million)
Figure 38. Asia Biosynthesis of Cannabinoids Market Share by Type (2018-2029)
Figure 39. Asia Biosynthesis of Cannabinoids Market Share by Application (2018-2029)
Figure 40. Asia Biosynthesis of Cannabinoids Market Share by Region (2018-2029)
Figure 41. Japan Biosynthesis of Cannabinoids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. South Korea Biosynthesis of Cannabinoids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. China Taiwan Biosynthesis of Cannabinoids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Southeast Asia Biosynthesis of Cannabinoids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. India Biosynthesis of Cannabinoids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Australia Biosynthesis of Cannabinoids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Biosynthesis of Cannabinoids Market Size YoY (2018-2029) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Biosynthesis of Cannabinoids Market Share by Type (2018-2029)
Figure 49. Middle East, Africa, and Latin America Biosynthesis of Cannabinoids Market Share by Application (2018-2029)
Figure 50. Middle East, Africa, and Latin America Biosynthesis of Cannabinoids Market Share by Country (2018-2029)
Figure 51. Brazil Biosynthesis of Cannabinoids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Mexico Biosynthesis of Cannabinoids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Turkey Biosynthesis of Cannabinoids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Saudi Arabia Biosynthesis of Cannabinoids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Israel Biosynthesis of Cannabinoids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. GCC Countries Biosynthesis of Cannabinoids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. Anandia Laboratories Revenue Growth Rate in Biosynthesis of Cannabinoids Business (2018-2023)
Figure 58. Gingko Bioworks Revenue Growth Rate in Biosynthesis of Cannabinoids Business (2018-2023)
Figure 59. Hyasynth Bio Revenue Growth Rate in Biosynthesis of Cannabinoids Business (2018-2023)
Figure 60. InMed Pharmaceuticals Revenue Growth Rate in Biosynthesis of Cannabinoids Business (2018-2023)
Figure 61. Librede Revenue Growth Rate in Biosynthesis of Cannabinoids Business (2018-2023)
Figure 62. Renew Biopharma Revenue Growth Rate in Biosynthesis of Cannabinoids Business (2018-2023)
Figure 63. Cronos Group Revenue Growth Rate in Biosynthesis of Cannabinoids Business (2018-2023)
Figure 64. Organigram Revenue Growth Rate in Biosynthesis of Cannabinoids Business (2018-2023)
Figure 65. Teewinot Life Sciences Revenue Growth Rate in Biosynthesis of Cannabinoids Business (2018-2023)
Figure 66. ICC International Cannabis Corp. Revenue Growth Rate in Biosynthesis of Cannabinoids Business (2018-2023)
Figure 67. Biotii Technologies Corp. Revenue Growth Rate in Biosynthesis of Cannabinoids Business (2018-2023)
Figure 68. Bristol-Myers Squibb Revenue Growth Rate in Biosynthesis of Cannabinoids Business (2018-2023)
Figure 69. Biogen Inc. Revenue Growth Rate in Biosynthesis of Cannabinoids Business (2018-2023)
Figure 70. GW Pharmaceuticals Revenue Growth Rate in Biosynthesis of Cannabinoids Business (2018-2023)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
Figure 1. Global Biosynthesis of Cannabinoids Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Biosynthesis of Cannabinoids Market Share by Type: 2022 VS 2029
Figure 3. THC Features
Figure 4. CBD Features
Figure 5. Others Features
Figure 6. Global Biosynthesis of Cannabinoids Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Biosynthesis of Cannabinoids Market Share by Application: 2022 VS 2029
Figure 8. Food Industry Case Studies
Figure 9. Medical Industry Case Studies
Figure 10. Others Case Studies
Figure 11. Biosynthesis of Cannabinoids Report Years Considered
Figure 12. Global Biosynthesis of Cannabinoids Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Biosynthesis of Cannabinoids Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Biosynthesis of Cannabinoids Market Share by Region: 2022 VS 2029
Figure 15. Global Biosynthesis of Cannabinoids Market Share by Players in 2022
Figure 16. Global Top Biosynthesis of Cannabinoids Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biosynthesis of Cannabinoids as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Biosynthesis of Cannabinoids Revenue in 2022
Figure 18. North America Biosynthesis of Cannabinoids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Biosynthesis of Cannabinoids Market Share by Type (2018-2029)
Figure 20. North America Biosynthesis of Cannabinoids Market Share by Application (2018-2029)
Figure 21. North America Biosynthesis of Cannabinoids Market Share by Country (2018-2029)
Figure 22. United States Biosynthesis of Cannabinoids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Canada Biosynthesis of Cannabinoids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Biosynthesis of Cannabinoids Market Size YoY (2018-2029) & (US$ Million)
Figure 25. Europe Biosynthesis of Cannabinoids Market Share by Type (2018-2029)
Figure 26. Europe Biosynthesis of Cannabinoids Market Share by Application (2018-2029)
Figure 27. Europe Biosynthesis of Cannabinoids Market Share by Country (2018-2029)
Figure 28. Germany Biosynthesis of Cannabinoids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. France Biosynthesis of Cannabinoids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. U.K. Biosynthesis of Cannabinoids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Italy Biosynthesis of Cannabinoids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Russia Biosynthesis of Cannabinoids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Nordic Countries Biosynthesis of Cannabinoids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. China Biosynthesis of Cannabinoids Market Size YoY (2018-2029) & (US$ Million)
Figure 35. China Biosynthesis of Cannabinoids Market Share by Type (2018-2029)
Figure 36. China Biosynthesis of Cannabinoids Market Share by Application (2018-2029)
Figure 37. Asia Biosynthesis of Cannabinoids Market Size YoY (2018-2029) & (US$ Million)
Figure 38. Asia Biosynthesis of Cannabinoids Market Share by Type (2018-2029)
Figure 39. Asia Biosynthesis of Cannabinoids Market Share by Application (2018-2029)
Figure 40. Asia Biosynthesis of Cannabinoids Market Share by Region (2018-2029)
Figure 41. Japan Biosynthesis of Cannabinoids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. South Korea Biosynthesis of Cannabinoids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. China Taiwan Biosynthesis of Cannabinoids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Southeast Asia Biosynthesis of Cannabinoids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. India Biosynthesis of Cannabinoids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Australia Biosynthesis of Cannabinoids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Biosynthesis of Cannabinoids Market Size YoY (2018-2029) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Biosynthesis of Cannabinoids Market Share by Type (2018-2029)
Figure 49. Middle East, Africa, and Latin America Biosynthesis of Cannabinoids Market Share by Application (2018-2029)
Figure 50. Middle East, Africa, and Latin America Biosynthesis of Cannabinoids Market Share by Country (2018-2029)
Figure 51. Brazil Biosynthesis of Cannabinoids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Mexico Biosynthesis of Cannabinoids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Turkey Biosynthesis of Cannabinoids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Saudi Arabia Biosynthesis of Cannabinoids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Israel Biosynthesis of Cannabinoids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. GCC Countries Biosynthesis of Cannabinoids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. Anandia Laboratories Revenue Growth Rate in Biosynthesis of Cannabinoids Business (2018-2023)
Figure 58. Gingko Bioworks Revenue Growth Rate in Biosynthesis of Cannabinoids Business (2018-2023)
Figure 59. Hyasynth Bio Revenue Growth Rate in Biosynthesis of Cannabinoids Business (2018-2023)
Figure 60. InMed Pharmaceuticals Revenue Growth Rate in Biosynthesis of Cannabinoids Business (2018-2023)
Figure 61. Librede Revenue Growth Rate in Biosynthesis of Cannabinoids Business (2018-2023)
Figure 62. Renew Biopharma Revenue Growth Rate in Biosynthesis of Cannabinoids Business (2018-2023)
Figure 63. Cronos Group Revenue Growth Rate in Biosynthesis of Cannabinoids Business (2018-2023)
Figure 64. Organigram Revenue Growth Rate in Biosynthesis of Cannabinoids Business (2018-2023)
Figure 65. Teewinot Life Sciences Revenue Growth Rate in Biosynthesis of Cannabinoids Business (2018-2023)
Figure 66. ICC International Cannabis Corp. Revenue Growth Rate in Biosynthesis of Cannabinoids Business (2018-2023)
Figure 67. Biotii Technologies Corp. Revenue Growth Rate in Biosynthesis of Cannabinoids Business (2018-2023)
Figure 68. Bristol-Myers Squibb Revenue Growth Rate in Biosynthesis of Cannabinoids Business (2018-2023)
Figure 69. Biogen Inc. Revenue Growth Rate in Biosynthesis of Cannabinoids Business (2018-2023)
Figure 70. GW Pharmaceuticals Revenue Growth Rate in Biosynthesis of Cannabinoids Business (2018-2023)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
